ImmunoMet Appoints Vincent J. O'Neill, M.D., B.Sc., M.R.C.P, as Chief Medical Officer, and Allan L. Shaw as Chief Financial Officer

HOUSTON, Feb. 12, 2018 -- (Healthcare Sales & Marketing Network) -- ImmunoMet Therapeutics, a private biotechnology company focused on utilizing cellular metabolism to develop novel anti-tumor and immuno-oncology therapies, today announced the appointment... Biopharmaceuticals, Oncology, Personnel ImmunoMet Therapeutics, immunotherapy, immunotherapies
Source: HSMN NewsFeed - Category: Pharmaceuticals Source Type: news